Q4 2024 lobbying disclosure forms have now been filed, so we are taking a quick look at updates since our last review. Sign-in or join Pα+ to continue reading this Issue of the Psychedelic Bulletin… Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.

Source

Previous articlePsychedelic Funding, Public Markets, and M&A in 2024
Next articleMagic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects